医院革兰阴性菌感染的防治策略  

Advances on Hospital-Acquired Infections Due to Gram-Negative Bacteria

作　　者：李性天[1] 耿立坚[1] 周密妹[1] 

机构地区：[1]武汉科技大学附属天佑医院,湖北武汉430064

出　　处：《中国药业》2011年第7期1-3,共3页China Pharmaceuticals

摘　　要：医院感染30%以上为革兰阴性菌感染,其中肠杆菌科细菌最常见,而多耐药细菌如铜绿假单胞菌、鲍曼不动杆菌、产超广谱β-内酰胺酶或产碳青霉烯酶肠杆菌科细菌在全球范围有增加流行的态势。该文针对此类细菌所引起的下呼吸道感染、血流感染和尿路感染,综合新近文献资料,提供一套有循证医学基础的抗感染用药方案,供临床选用。The Gram-negative bacteria is responsible for more than 30%of hospital-acquired infections,the Enterobacteriaceae family being the most commonly identified group overall,multidrug-resistant organisms,including P Aeruginosa,A Baumannii,and extended-spectrumβ-lactamase-producing or carbapenemase-producing Enterobacteriaceae are increasingly being reported worldwide.The article put forward the potentially useful antibiotic regimens for lower respiratory tract,bloodstream infections and urinary tract infections that caused by these organisms.

关 键 词：革兰阴性菌 肺炎 血流感染 尿路感染 抗感染药物 

分 类 号：R969.3[医药卫生—药理学] R978[医药卫生—药学]